RXYLT1 Gene Muscular Dystrophy-Dystroglycanopathy Congenital with Brain and Eye Anomalies Type A10 Genetic Test sale cost 4400 AED
SDHA Gene Mitochondrial Respiratory Chain Complex II Deficiency Genetic Test sale cost 4400 AED SDHA Gene Mitochondrial Respiratory Chain Complex II Deficiency Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
SLC5A7 Gene Myasthenic Syndrome Congenital Type 20 Presynaptic Genetic Test sale cost 4400 AED SLC5A7 Gene Myasthenic Syndrome Congenital Type 20 Presynaptic Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

RXYLT1 Gene Muscular Dystrophy-Dystroglycanopathy Congenital with Brain and Eye Anomalies Type A10 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The RXYLT1 gene muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies type A10 genetic test is a specialized diagnostic assessment offered by DNA Labs UAE. This test is designed to identify mutations in the RXYLT1 gene, which are associated with a rare form of muscular dystrophy known as dystroglycanopathy congenital with brain and eye anomalies type A10. This condition is characterized by muscle weakness and wasting, along with severe developmental issues affecting the brain and eyes.

The genetic test involves analyzing the patient’s DNA to detect any abnormalities or mutations in the RXYLT1 gene that may lead to the disease. Early diagnosis through this genetic testing is crucial for managing symptoms, planning treatment strategies, and providing genetic counseling to affected families.

DNA Labs UAE, a leading provider of genetic testing services in the region, offers this comprehensive test at a cost of 4400 AED. The test is conducted in their state-of-the-art facilities, ensuring high-quality, reliable results. By opting for this test at DNA Labs UAE, patients and their families can gain valuable insights into their genetic makeup, enabling them to make informed decisions about their health and future.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

RXYLT1 Gene Muscular Dystrophy-Dystroglycanopathy Congenital with Brain and Eye Anomalies Type A10 Genetic Test

Test Name: RXYLT1 Gene Muscular Dystrophy-Dystroglycanopathy Congenital with Brain and Eye Anomalies Type A10 Genetic Test

Components: Blood or Extracted DNA or One drop Blood on FTA Card

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Neurological Disorders

Doctor: Neurologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for RXYLT1 Gene Muscular Dystrophy-Dystroglycanopathy (Congenital with Brain and Eye Anomalies), Type A10 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with RXYLT1 Gene Muscular Dystrophy-Dystroglycanopathy (Congenital with Brain and Eye Anomalies), Type A10

Test Details

The RXYLT1 gene is associated with a type of muscular dystrophy called muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A10. This condition is characterized by muscle weakness and wasting, brain abnormalities, and eye anomalies.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technologies to analyze multiple genes simultaneously. In the case of RXYLT1 gene testing, NGS can identify any mutations or variations in the RXYLT1 gene that may be responsible for the development of muscular dystrophy-dystroglycanopathy, type A10.

Genetic testing for RXYLT1 gene mutations can help in confirming a diagnosis, predicting the severity of the condition, providing information about the inheritance pattern, and assisting in family planning decisions. It can also be useful for genetic counseling and potentially guiding treatment options in the future.

Test Name RXYLT1 Gene Muscular dystrophy-dystroglycanopathy congenital with brain and eye anomalies type A10 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for RXYLT1 Gene Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A10 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with RXYLT1 Gene Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A10
Test Details

The RXYLT1 gene is associated with a type of muscular dystrophy called muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A10. This condition is characterized by muscle weakness and wasting, brain abnormalities, and eye anomalies.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technologies to analyze multiple genes simultaneously. In the case of RXYLT1 gene testing, NGS can identify any mutations or variations in the RXYLT1 gene that may be responsible for the development of muscular dystrophy-dystroglycanopathy, type A10.

Genetic testing for RXYLT1 gene mutations can help in confirming a diagnosis, predicting the severity of the condition, providing information about the inheritance pattern, and assisting in family planning decisions. It can also be useful for genetic counseling and potentially guiding treatment options in the future.

SKU: TEST-1756 Category:

Related products